uniQure N.V.
NASDAQ:QUREBiotechnology
Healthcare
$20.23 -2.34%
-$1.13 today
- Market cap
- $1.42B
- Beta
- 1.00
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$3.33
52W Low $8.73High $71.50
Volume 1.16M
Average 1.75M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$177.96M
FY 2025 · Annual
Investing Cash Flow
-$321.62M
FY 2025 · Annual
Financing Cash Flow
$415.40M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 329.59M | (126.79M) | (308.48M) | (239.56M) | (198.97M) |
| Depreciation & Amortization | 7.3M | 8.54M | 11.9M | 12.64M | 14.76M |
| Deferred Income Tax | 3.21M | (1.47M) | 1.92M | 2.43M | 1.59M |
| Stock-Based Compensation | 25.64M | 34.2M | 35.09M | 22.26M | 17.68M |
| Change in Working Capital | (50.48M) | (43.38M) | 81.12M | (3.94M) | (6.79M) |
| Accounts Receivables | (58.96M) | (49.08M) | (1.32M) | (2.24M) | (8.6M) |
| Inventory | 0 | (6.92M) | (6.74M) | 2.42M | 0 |
| Accounts Payables | (727K) | 9.24M | (4.17M) | 1.52M | (2.67M) |
| Other Working Capital | 9.2M | 3.39M | 93.36M | (5.64M) | 4.47M |
| Other Non-Cash Items | (27.29M) | (16.16M) | 32.51M | 23.44M | (6.23M) |
| Operating Cash Flow | 287.96M | (145.06M) | (145.93M) | (182.73M) | (177.96M) |
| Capital Expenditures | (17.44M) | (17.69M) | (7.15M) | (3.37M) | (439K) |
| Acquisitions (Net) | (49.95M) | (1.9M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | (163.15M) | (366.44M) | (359.84M) | (658.37M) |
| Sales of Investments | 0 | 0 | 167.91M | 534.5M | 337.2M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (67.39M) | (182.73M) | (205.69M) | 162.97M | (321.62M) |
| Debt Repayment | 62.5M | 0 | 370.06M | (53.05M) | 0 |
| Common Stock Issued | 33.7M | 1.45M | 308K | 2.12M | 391.9M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.33M) | 0 | (7.65M) | (8.56M) | 23.5M |
| Financing Cash Flow | 94.86M | 1.45M | 362.72M | (59.49M) | 415.4M |
| Effect of Forex Changes | (3.76M) | (1.83M) | 2.27M | (4.97M) | 5.49M |
| Net Change in Cash | 311.67M | (328.18M) | 13.37M | (84.22M) | (78.69M) |
| Free Cash Flow | 270.52M | (162.75M) | (153.08M) | (186.1M) | (177.96M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$199.0M
+ D&A$14.8M
+ Stock-Based Comp$17.7M
+ Deferred Tax$1.6M
- Working Capital-$6.8M
- Other Non-Cash-$6.2M
= Operating Cash Flow-$178.0M
- Capex-$439.0K
= Free Cash Flow-$178.0M
Analysis
FY2025 free cash flow is -$178.0M. FCF conversion is 89.4% of net income. Operating cash flow was -$178.0M, with capex of -$439.0K. The largest bridge item is Stock-Based Comp at $17.7M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 10, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 3, 2026 | |
| 8-K | Current report | Nov 2, 2026 |
Does QURE generate free cash flow?
uniQure N.V. (QURE) generated -$177.96M of free cash flow in fiscal 2025.
How much operating cash flow does QURE produce?
Operating cash flow was -$177.96M, before capital expenditures of $439,000.00.
Continue the stock analysis
Jump to another research area for this company.